Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000369851 | GNAI3-201 | 27174 | - | ENSP00000358867 | 354 (aa) | - | P08754 |
Pathway ID | Pathway Name | Source |
---|---|---|
hsa04015 | Rap1 signaling pathway | KEGG |
hsa04022 | cGMP-PKG signaling pathway | KEGG |
hsa04024 | cAMP signaling pathway | KEGG |
hsa04062 | Chemokine signaling pathway | KEGG |
hsa04071 | Sphingolipid signaling pathway | KEGG |
hsa04261 | Adrenergic signaling in cardiomyocytes | KEGG |
hsa04360 | Axon guidance | KEGG |
hsa04371 | Apelin signaling pathway | KEGG |
hsa04540 | Gap junction | KEGG |
hsa04611 | Platelet activation | KEGG |
hsa04670 | Leukocyte transendothelial migration | KEGG |
hsa04713 | Circadian entrainment | KEGG |
hsa04723 | Retrograde endocannabinoid signaling | KEGG |
hsa04724 | Glutamatergic synapse | KEGG |
hsa04725 | Cholinergic synapse | KEGG |
hsa04726 | Serotonergic synapse | KEGG |
hsa04727 | GABAergic synapse | KEGG |
hsa04728 | Dopaminergic synapse | KEGG |
hsa04730 | Long-term depression | KEGG |
hsa04914 | Progesterone-mediated oocyte maturation | KEGG |
hsa04915 | Estrogen signaling pathway | KEGG |
hsa04916 | Melanogenesis | KEGG |
hsa04921 | Oxytocin signaling pathway | KEGG |
hsa04923 | Regulation of lipolysis in adipocytes | KEGG |
hsa04924 | Renin secretion | KEGG |
hsa04926 | Relaxin signaling pathway | KEGG |
hsa04928 | Parathyroid hormone synthesis, secretion and action | KEGG |
hsa04934 | Cushing syndrome | KEGG |
hsa04971 | Gastric acid secretion | KEGG |
hsa05012 | Parkinson disease | KEGG |
hsa05030 | Cocaine addiction | KEGG |
hsa05032 | Morphine addiction | KEGG |
hsa05034 | Alcoholism | KEGG |
hsa05133 | Pertussis | KEGG |
hsa05142 | Chagas disease (American trypanosomiasis) | KEGG |
hsa05145 | Toxoplasmosis | KEGG |
hsa05163 | Human cytomegalovirus infection | KEGG |
hsa05170 | Human immunodeficiency virus 1 infection | KEGG |
hsa05200 | Pathways in cancer | KEGG |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Hip circumference | 25673412 | [0.044-0.083] unit decrease | 0.0632 | EFO_0005093 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Hip circumference | 25673412 | [0.058-0.11] unit decrease | 0.0842 | EFO_0005093 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Childhood body mass index | 26604143 | EFO_0004340 | ||
ENSG00000065135 | rs17024258 | 1 | 109604699 | T | Obesity | 23563607 | [NR] | 1.25 | EFO_0001073 |
ENSG00000065135 | rs6537837 | 1 | 109577110 | T | Major depressive disorder | 20125088 | 1.43 | EFO_0003761 | |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index in physically active individuals | 28448500 | [0.056-0.099] kg/m2 increase | 0.0775 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | ? | Body mass index (joint analysis main effects and physical activity interaction) | 28448500 | EFO_0008002|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | ? | Body mass index (joint analysis main effects and physical activity interaction) | 28448500 | EFO_0008002|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | BMI (adjusted for smoking behaviour) | 28443625 | [0.044-0.089] kg/m2 decrease | 0.0661 | EFO_0004318|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | BMI (adjusted for smoking behaviour) | 28443625 | [0.048-0.083] kg/m2 decrease | 0.0656 | EFO_0004318|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | BMI (adjusted for smoking behaviour) | 28443625 | [0.037-0.091] kg/m2 decrease | 0.0641 | EFO_0004318|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Body mass index (joint analysis main effects and smoking interaction) | 28443625 | EFO_0004318|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Body mass index (joint analysis main effects and smoking interaction) | 28443625 | EFO_0004318|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | BMI in non-smokers | 28443625 | [0.043-0.084] kg/m2 decrease | 0.0632 | EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | BMI in non-smokers | 28443625 | [0.035-0.085] kg/m2 decrease | 0.06 | EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 28448500 | [0.058-0.096] kg/m2 increase | 0.0771 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 28448500 | [0.041-0.101] kg/m2 increase | 0.0709 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 28448500 | [0.063-0.104] kg/m2 increase | 0.0835 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 28448500 | [0.061-0.115] kg/m2 increase | 0.0881 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 28448500 | [0.044-0.101] kg/m2 increase | 0.0723 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index in physically active individuals | 28448500 | [0.061-0.12] kg/m2 increase | 0.0906 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index in physically active individuals | 28448500 | [0.06-0.106] kg/m2 increase | 0.0831 | EFO_0008002|EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | ? | Body mass index (joint analysis main effects and physical activity interaction) | 28448500 | EFO_0008002|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | ? | Body mass index (joint analysis main effects and physical activity interaction) | 28448500 | EFO_0008002|EFO_0004340 | ||
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Hand grip strength | 29691431 | [0.0032-0.0068] unit increase | 0.005 | EFO_0006941 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | T | Body mass index | 30108127 | [NR] unit decrease | 0.053 | EFO_0004340 |
ENSG00000065135 | rs17024393 | 1 | 109612066 | C | Body mass index | 26961502 | [0.045-0.095] unit increase | 0.07 | EFO_0004340 |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0000139 | Golgi membrane | 12642577. | IDA | Component |
GO:0001664 | G protein-coupled receptor binding | 21873635. | IBA | Function |
GO:0003924 | GTPase activity | 21873635. | IBA | Function |
GO:0003924 | GTPase activity | 19478087. | IDA | Function |
GO:0005515 | protein binding | 18434541.21988832.25416956. | IPI | Function |
GO:0005525 | GTP binding | - | IEA | Function |
GO:0005634 | nucleus | - | IDA | Component |
GO:0005730 | nucleolus | - | IDA | Component |
GO:0005737 | cytoplasm | 17635935. | IDA | Component |
GO:0005765 | lysosomal membrane | 17897319. | HDA | Component |
GO:0005789 | endoplasmic reticulum membrane | 12642577. | IDA | Component |
GO:0005813 | centrosome | 17635935. | IDA | Component |
GO:0005834 | heterotrimeric G-protein complex | 21873635. | IBA | Component |
GO:0005886 | plasma membrane | 17635935. | IDA | Component |
GO:0005886 | plasma membrane | - | TAS | Component |
GO:0006457 | protein folding | - | TAS | Process |
GO:0006906 | vesicle fusion | - | IEA | Process |
GO:0007049 | cell cycle | - | IEA | Process |
GO:0007186 | G protein-coupled receptor signaling pathway | - | TAS | Process |
GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 21873635. | IBA | Process |
GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 19478087. | IDA | Process |
GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | - | TAS | Process |
GO:0007194 | negative regulation of adenylate cyclase activity | 7608168. | TAS | Process |
GO:0007212 | dopamine receptor signaling pathway | 19478087. | IDA | Process |
GO:0007420 | brain development | - | IEA | Process |
GO:0016020 | membrane | 19946888. | HDA | Component |
GO:0016239 | positive regulation of macroautophagy | 12642577. | IMP | Process |
GO:0019003 | GDP binding | 19478087. | IDA | Function |
GO:0019904 | protein domain specific binding | - | IEA | Function |
GO:0030496 | midbody | 17635935. | IDA | Component |
GO:0031683 | G-protein beta/gamma-subunit complex binding | 21873635. | IBA | Function |
GO:0031821 | G protein-coupled serotonin receptor binding | - | IEA | Function |
GO:0032794 | GTPase activating protein binding | - | IEA | Function |
GO:0032930 | positive regulation of superoxide anion generation | - | IEA | Process |
GO:0033864 | positive regulation of NAD(P)H oxidase activity | - | IEA | Process |
GO:0042588 | zymogen granule | - | IEA | Component |
GO:0045121 | membrane raft | - | IEA | Component |
GO:0046039 | GTP metabolic process | 19478087. | IDA | Process |
GO:0046872 | metal ion binding | - | IEA | Function |
GO:0051301 | cell division | 17635935. | IDA | Process |
GO:0070062 | extracellular exosome | 19056867.20458337. | HDA | Component |
GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | - | IEA | Process |
GO:2001234 | negative regulation of apoptotic signaling pathway | - | IEA | Process |